Medical expenditures for children with an autism spectrum disorder in a privately insured population

被引:109
作者
Shimabukuro, Tom T. [1 ]
Grosse, Scott D. [2 ]
Rice, Catherine [2 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunol & Resp Dis, Immunol Serv Div, Hlth Serv Res & Evaluat Branch, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA
关键词
autism; autism spectrum disorders; medical expenditures; incremental cost; cost ratio;
D O I
10.1007/s10803-007-0424-y
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
This study provides estimates of medical expenditures for a subset of children and adolescents who receive employer-based health insurance and have a medical diagnosis of an autism spectrum disorder (ASD). Data analyzed were from the 2003 MarketScan((R)) research databases. Individuals with an ASD had average medical expenditures that exceeded those without an ASD by $4,110-$6,200 per year. On average, medical expenditures for individuals with an ASD were 4.1-6.2 times greater than for those without an ASD. Differences in median expenditures ranged from $2,240 to $3,360 per year with median expenditures 8.4-9.5 times greater. These findings add to a growing body of evidence that children and adolescents with medical diagnoses of an ASD incur elevated medical utilization and costs.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 19 条
[1]   Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio [J].
Aman, MG ;
Lam, KSL ;
Collier-Crespin, A .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2003, 33 (05) :527-534
[2]  
[Anonymous], 2006, Understanding Autism: From Basic Neuroscience to Treatment, DOI DOI 10.1201/9781420004205.CH20
[3]   A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan [J].
Croen, Lisa A. ;
Najjar, Daniel V. ;
Ray, G. Thomas ;
Lotspeich, Linda ;
Bernal, Pilar .
PEDIATRICS, 2006, 118 (04) :E1203-E1211
[4]   Parental report of health conditions and health care use among children with and without autism -: National Survey of Children's Health [J].
Gurney, James G. ;
McPheeters, Melissa L. ;
Davis, Matthew M. .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (08) :825-830
[5]   The economic impact of autism in Britain [J].
Järbrink, K ;
Knapp, M .
AUTISM, 2001, 5 (01) :7-22
[6]   Prevalence and patterns of use of psychoactive medicines in individuals with autism in the autism society of North Carolina [J].
Langworthy-Lam, KS ;
Aman, MG ;
Van Bourgondien, ME .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2002, 12 (04) :311-321
[7]   Health care utilization and expenditures for children with autism: Data from US national samples [J].
Liptak, Gregory S. ;
Stuart, Tami ;
Auinger, Peggy .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2006, 36 (07) :871-879
[8]   Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999 [J].
Mandell, David S. ;
Cao, Jun ;
Ittenbach, Richard ;
Pinto-Martin, Jennifer .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2006, 36 (04) :475-485
[9]   Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use [J].
Martin, A ;
Scahill, L ;
Klin, A ;
Volkmar, FR .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (07) :923-931
[10]   Autism: An emerging public health problem [J].
Newschaffer, CJ ;
Curran, LK .
PUBLIC HEALTH REPORTS, 2003, 118 (05) :393-399